As the global economy mends, the 2021 growth of Attention Deficit and Hyperactivity Disorder will have significant change from previous year. According to our researcher latest study, the global Attention Deficit and Hyperactivity Disorder market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Attention Deficit and Hyperactivity Disorder market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Attention Deficit and Hyperactivity Disorder market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Attention Deficit and Hyperactivity Disorder market, reaching US$ million by the year 2028. As for the Europe Attention Deficit and Hyperactivity Disorder landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Attention Deficit and Hyperactivity Disorder players cover Takeda, Johnson & Johnson, Novartis, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Attention Deficit and Hyperactivity Disorder market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Stimulant

Non-stimulant

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospital

Retail Pharmacy

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Takeda

Johnson & Johnson

Novartis

Eli Lilly

Tris Pharma

Neos Therapeutics

Mallinckrodt

Amneal Pharmaceuticals

Noven Pharmaceuticals

Purdue Parma